Wednesday June 10, 2026 | EN FR AR Live

Health

WHO Approves First-Ever Malaria Treatment for Newborns: A Game-Changer for Africa

Society & Culture / Leave a Comment

In a historic move that could transform child health outcomes across Africa, the World Health Organization (WHO) has prequalified the first-ever malaria treatment specifically formulated for newborns and young infants. The treatment—a pediatric formulation of artemether-lumefantrine, marketed as Coartem Baby—received WHO prequalification on April 24, 2026, just ahead of World Malaria Day on April 25. […]

WHO Approves First-Ever Malaria Treatment for Newborns: A Game-Changer for Africa Read More »

Africa’s Silent Pandemic: Antimicrobial Resistance Is Killing More People Than HIV and Malaria Combined

Conflict & Security / Leave a Comment

While the world’s attention remains fixed on emerging infectious disease threats, a quieter — and in many ways deadlier — crisis has taken root across the African continent. Antimicrobial resistance (AMR), the process by which bacteria, viruses, fungi, and parasites evolve to defeat the drugs designed to kill them, is now responsible for more deaths

Africa’s Silent Pandemic: Antimicrobial Resistance Is Killing More People Than HIV and Malaria Combined Read More »

Senegal’s Harsh Anti-Gay Law Threatens to Undo Decades of Progress in the Fight Against HIV

Society & Culture / Leave a Comment

When Senegal’s parliament approved one of Africa’s most punitive anti-LGBT laws in March 2026, advocates for people living with HIV feared the worst. Their concerns are now being confirmed. New data suggests that access to testing, treatment, and prevention services for vulnerable populations has collapsed, threatening to unravel one of sub-Saharan Africa’s most celebrated HIV

Senegal’s Harsh Anti-Gay Law Threatens to Undo Decades of Progress in the Fight Against HIV Read More »

Gene Editing Offers Hope for Africa’s Sickle Cell Patients — But Price Tag Makes Cure a Distant Dream

Politics & Governance / Leave a Comment

Revolutionary CRISPR-based sickle cell therapies are raising unprecedented hope across Africa — the continent that carries 85 percent of the global disease burden — even as the $2.2 million price tag places cures forever out of reach for most patients.

Gene Editing Offers Hope for Africa’s Sickle Cell Patients — But Price Tag Makes Cure a Distant Dream Read More »